Skip to main content
Top
Published in: Irish Journal of Medical Science (1971 -) 1/2019

01-02-2019 | Original Article

Breast screening in symptomatic women over 35 years of age: improvements in service efficiency

Authors: Roisin M. O’Cearbhaill, Sandra Hembrecht, Liam A. Devane, Jane Rothwell, Denis Evoy, James Geraghty, Damian P. McCartan, Sorcha McNally, Ann O’Doherty, Enda W. McDermott, Ruth S. Prichard

Published in: Irish Journal of Medical Science (1971 -) | Issue 1/2019

Login to get access

Abstract

Introduction

The rationalization of cancer services in Ireland saw all women with symptomatic breast problems referred to one of the eight regional cancer centers. A pilot triaging system was introduced in St Vincent’s University Hospital to streamline these services. Women over 35 years who do not meet urgent referral criteria are referred for a mammogram prior to a clinic appointment (“image first”). The aim of this study was to retrospectively determine the recall rates, biopsy rates, and rate of breast cancer identification within this cohort of patients. This was compared to a screening population of patients.

Methods

Patients triaged into the “image first” group within a one-year period were identified. Results of the initial mammogram, further imaging and subsequent biopsies were recorded. Data relating to number of recalls, number of patients biopsied and number of cancers identified within the Merrion Unit of the National Breastcheck Screening Program was obtained for comparison.

Results

One thousand six hundred eighty-eight referrals were triaged as “image first” over this period. 185 (11%) of patients required a biopsy of an identified lesion. Breast cancer was diagnosed in 65 patients (3.9%). During the same study period, of the 42,099 women who were screened for breast cancer, 496 (1.8%) underwent biopsy and 267 (0.63%) were diagnosed with breast cancer.

Conclusion

Image first patients, who represent a cohort of “symptomatic” non-urgent women, have a greater rate of breast cancer detection than an asymptomatic screening population. This may have an impact on the appropriate triaging of symptomatic women in a national cancer center.
Literature
1.
go back to reference A strategy for cancer control in Ireland (2006) National Cancer Forum-Department of Health and Children A strategy for cancer control in Ireland (2006) National Cancer Forum-Department of Health and Children
2.
go back to reference Programme NCC, O’Rourke N (2012) Review of referral patterns and triage processes in symptomatic breast units. A hospital perspective. National Cancer Control Programme Programme NCC, O’Rourke N (2012) Review of referral patterns and triage processes in symptomatic breast units. A hospital perspective. National Cancer Control Programme
3.
go back to reference Programme NCC (2013) Report for 2011 on the symptomatic breast disease key performance indicators Programme NCC (2013) Report for 2011 on the symptomatic breast disease key performance indicators
4.
go back to reference Programme NCC (2009) National Breast Cancer GP Referral Guidelines. National Breast Cancer GP Referral Guidelines Programme NCC (2009) National Breast Cancer GP Referral Guidelines. National Breast Cancer GP Referral Guidelines
5.
go back to reference Neary M, Lowery AJ, O’Conghaile A et al (2011) NCCP breast cancer referral guidelines—are breast cancer patients prioritised? Ir Med J 104(2):39–41PubMed Neary M, Lowery AJ, O’Conghaile A et al (2011) NCCP breast cancer referral guidelines—are breast cancer patients prioritised? Ir Med J 104(2):39–41PubMed
6.
go back to reference Ahmed A, Marginan A, Sweeney K, Malone C, McLaughlin R, Kerin M (2016) Medicolegal implications of accuracy of GP referral letters to specialist breast clinic. Ir J Med Sci 185(1):69–73CrossRefPubMed Ahmed A, Marginan A, Sweeney K, Malone C, McLaughlin R, Kerin M (2016) Medicolegal implications of accuracy of GP referral letters to specialist breast clinic. Ir J Med Sci 185(1):69–73CrossRefPubMed
7.
go back to reference Kolb TM, Lichy J, Newhouse JH (2002) Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations. Radiology 225(1):165–175CrossRef Kolb TM, Lichy J, Newhouse JH (2002) Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations. Radiology 225(1):165–175CrossRef
8.
go back to reference Carney PA, Miglioretti DL, Yankaskas BC (2003) Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med 138(3):168–175CrossRef Carney PA, Miglioretti DL, Yankaskas BC (2003) Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med 138(3):168–175CrossRef
9.
go back to reference Purushothaman HN, Wilson R, Michell MJ (2012) Medico-legal issues in breast imaging. Clin Radiol 67(7):638–642CrossRefPubMed Purushothaman HN, Wilson R, Michell MJ (2012) Medico-legal issues in breast imaging. Clin Radiol 67(7):638–642CrossRefPubMed
10.
go back to reference Dee KE, Sickles EA (2001) Medical audit of diagnostic mammography examinations: comparison with screening outcomes obtained concurrently. AJR Am J Roentgenol 176(3):729–733CrossRefPubMed Dee KE, Sickles EA (2001) Medical audit of diagnostic mammography examinations: comparison with screening outcomes obtained concurrently. AJR Am J Roentgenol 176(3):729–733CrossRefPubMed
11.
go back to reference Wang WV, Tan SM, Chow WL (2011) The impact of mammographic breast cancer screening in Singapore: a comparison between screen-detected and symptomatic women. Asian Pac J Cancer Prev 12(10):2735–2740PubMed Wang WV, Tan SM, Chow WL (2011) The impact of mammographic breast cancer screening in Singapore: a comparison between screen-detected and symptomatic women. Asian Pac J Cancer Prev 12(10):2735–2740PubMed
12.
go back to reference Hofvind S, Holen A, Roman M et al (2016) Mode of detection: an independent prognostic factor for women with breast cancer. J Med Screen 23(2):89–97CrossRefPubMed Hofvind S, Holen A, Roman M et al (2016) Mode of detection: an independent prognostic factor for women with breast cancer. J Med Screen 23(2):89–97CrossRefPubMed
13.
go back to reference Redondo M, Funez R, Medina-Cano F, Rodrigo I, Acebal M, Tellez T, Roldan MJ, Hortas ML, Bellinvia A, Pereda T, Domingo L, Morales-Suarez Varela M, Sala M, Rueda A (2012) Detection methods predict differences in biology and survival in breast cancer patients. BMC Cancer 12:604CrossRefPubMedPubMedCentral Redondo M, Funez R, Medina-Cano F, Rodrigo I, Acebal M, Tellez T, Roldan MJ, Hortas ML, Bellinvia A, Pereda T, Domingo L, Morales-Suarez Varela M, Sala M, Rueda A (2012) Detection methods predict differences in biology and survival in breast cancer patients. BMC Cancer 12:604CrossRefPubMedPubMedCentral
14.
go back to reference Allgood PC, Duffy SW, Kearins O, O'Sullivan E, Tappenden N, Wallis MG, Lawrence G (2011) Explaining the difference in prognosis between screen-detected and symptomatic breast cancers. Br J Cancer 104(11):1680–1685CrossRefPubMedPubMedCentral Allgood PC, Duffy SW, Kearins O, O'Sullivan E, Tappenden N, Wallis MG, Lawrence G (2011) Explaining the difference in prognosis between screen-detected and symptomatic breast cancers. Br J Cancer 104(11):1680–1685CrossRefPubMedPubMedCentral
Metadata
Title
Breast screening in symptomatic women over 35 years of age: improvements in service efficiency
Authors
Roisin M. O’Cearbhaill
Sandra Hembrecht
Liam A. Devane
Jane Rothwell
Denis Evoy
James Geraghty
Damian P. McCartan
Sorcha McNally
Ann O’Doherty
Enda W. McDermott
Ruth S. Prichard
Publication date
01-02-2019
Publisher
Springer London
Published in
Irish Journal of Medical Science (1971 -) / Issue 1/2019
Print ISSN: 0021-1265
Electronic ISSN: 1863-4362
DOI
https://doi.org/10.1007/s11845-018-1794-1

Other articles of this Issue 1/2019

Irish Journal of Medical Science (1971 -) 1/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine